Skip to content
10-K

Annual Report

Edesa Biotech, Inc. EDSA

0001171843-25-007914

← back to feed
Filed
Dec 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 12, 2025 8.33M sh
Operating Cash Flow FY 2025 · Sep 30, 2025 −$7.32M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$4.89M
Cash And Equivalents FY 2025 · Sep 30, 2025 $10.8M
Stockholders Equity FY 2025 · Sep 30, 2025 $12.45M
Stockholders Equity FY 2025 · Sep 30, 2024 $1.98M
Stockholders Equity FY 2025 · Sep 30, 2023 $7.05M
Current Liabilities FY 2025 · Sep 30, 2025 $1.08M
Current Liabilities FY 2025 · Sep 30, 2024 $1.83M
Current Assets FY 2025 · Sep 30, 2025 $11.51M
Current Assets FY 2025 · Sep 30, 2024 $1.68M
Total Assets FY 2025 · Sep 30, 2025 $13.53M
Total Assets FY 2025 · Sep 30, 2024 $3.81M
Eps Basic FY 2025 · Sep 30, 2025 −$1.27
Eps Basic FY 2025 · Sep 30, 2024 −$1.93
Sga Expense FY 2025 · Sep 30, 2025 $4.24M
Sga Expense FY 2025 · Sep 30, 2024 $4.13M
Rd Expense FY 2025 · Sep 30, 2025 $3.67M
Rd Expense FY 2025 · Sep 30, 2024 $2.88M
Net Income FY 2025 · Sep 30, 2025 −$7.19M
Net Income FY 2025 · Sep 30, 2024 −$6.17M
Operating Income FY 2025 · Sep 30, 2025 −$7.91M
Operating Income FY 2025 · Sep 30, 2024 −$7.01M